Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-02 Sale | 2024-04-03 4:10 pm | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 12,115 | $9.86 | $119,454 | 322,839 (Direct) | View |
| 2024-02-21 Sale | 2024-02-22 4:34 pm | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 13,033 | $7.46 | $97,226 | 334,954 (Direct) | View |
| 2023-04-03 Sale | 2023-04-05 5:04 pm | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 7,437 | $7.83 | $58,232 | 214,618 (Direct) | View |
| 2021-06-07 Sale | 2021-06-09 7:05 pm | BIOGEN INC. | BIIB | Sandrock Alfred Head of Research & Development | 7,672 | $440 | $3,375,680 | 10,169 (Direct) | View |
| 2020-11-04 Sale | 2020-11-06 9:39 pm | BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development | 1,500 | $350 | $525,000 | 13,066 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-09 Option Award | 2024-02-16 4:59 pm | N/A 2034-02-09 | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 390,000 | $0 | 607,987 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-22 8:51 pm | N/A 2033-02-17 | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 360,000 | $0 | 462,055 (Direct) | View |
| 2022-03-22 Option Award | 2022-03-23 6:35 pm | N/A 2032-03-22 | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 1,040,600 | $0 | 1,040,600 (Direct) | View |
| 2022-02-07 Option Award | 2022-02-09 4:27 pm | N/A 2032-02-07 | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2021-02-18 Option Award | 2021-02-22 4:19 pm | N/A 2024-02-18 | BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development | 14,500 | $0 | 14,500 (Direct) | View |
| 2021-02-12 Exercise | 2021-02-17 5:01 pm | N/A 2021-02-12 | BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development | 4,454 | $0 | 46,486 (Direct) | View |
| 2021-02-12 Tax Withholding | 2021-02-17 5:01 pm | N/A N/A | BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development | 3,510 | $278.03 | 46,486 (Direct) | View |
| 2021-02-12 Other | 2021-02-17 5:01 pm | N/A 2021-02-12 | BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development | 5,772 | $0 | 46,486 (Direct) | View |
| 2021-01-27 Option Award | 2021-01-29 4:43 pm | N/A N/A | BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development | 3,728 | $0 | 16,794 (Direct) | View |
| 2020-02-15 Tax Withholding | 2020-02-19 6:17 pm | N/A N/A | BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development | 538 | $333 | 15,396 (Direct) | View |
| 2020-02-15 Exercise | 2020-02-19 6:17 pm | N/A 2020-02-15 | BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development | 1,213 | $0 | 15,396 (Direct) | View |
| 2020-02-15 Other | 2020-02-19 6:17 pm | N/A 2020-02-15 | BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development | 915 | $0 | 15,396 (Direct) | View |
| 2020-02-12 Tax Withholding | 2020-02-14 6:16 pm | N/A N/A | BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development | 1,901 | $331.76 | 48,373 (Direct) | View |
| 2020-02-12 Exercise | 2020-02-14 6:16 pm | N/A 2020-02-12 | BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development | 5,216 | $0 | 48,373 (Direct) | View |
| 2020-02-12 Option Award | 2020-02-14 6:16 pm | N/A 2023-02-12 | BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development | 12,060 | $0 | 48,373 (Direct) | View |
| 2020-02-12 Other | 2020-02-14 6:16 pm | N/A 2021-02-12 | BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development | 3,199 | $0 | 48,373 (Direct) | View |
| 2019-05-22 Option Award | 2019-05-23 5:46 pm | 2019-06-22 2029-05-22 | NEUROCRINE BIOSCIENCES INC | NBIX | Sandrock Alfred Director | 10,000 | $0 | 10,000 (Direct) | View |